A Novo Nordisk weight loss drug lowers BMI in kids as young as 6
In a late-stage clinical trial, a drug similar to Ozempic was shown to reduce body mass index in kids ages 6 to 11 with obesity, according to results published Tuesday in the New England Journal of Medicine.
What's Your Reaction?